Skip to content

Depression: all studies

Page 1018 of 1,036: studies 10,171 to 10,180 of 10,358, newest first. Back to the depression overview

Research

Helping at the edges of life: Perspectives of a psychedelic therapist

Journal of Near-Death Studies March 1, 1988 R. Yensen

A case history is presented of a 70 year old man treated with psychedelic psychotherapy for depression, anxiety, and pain associated with terminal cancer. Interpersonal and intrapersonal aspects of treatment following a single 90 mg dose of dipropyltryptamine (DPT) are described. Comparisons are made between transpersonal, mystical, and religious elements in psychedelic drug experiences and...

Medical Toxicology: Diagnosis and Treatment of Human Poisoning.

Annals of Internal Medicine March 1, 1988 957 citations

General Approach to the Poisoned Patient Introduction and Initial Evaluation. Diagnostic Services. Gut Decontamination. Enhancement and Elimination. Antidotes. Supportive Care. Pharmacokinetics. Toxic Exposure During Pregnancy. Therapeutic Drugs Acetaminophen. Anti-Arrhythmic Agents. Anti-Coagulants. Anti-Convulsants. Anti-Hypertensive Drugs. Anti-Infective Drugs. Anti-Depressants. Disulfiram....

DOI: 10.7326/0003-4819-108-3-502_9 (opens in new tab) Clinical toxicology Intensive care medicine Medical emergency Poison control

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

Neuropharmacology December 1987 Donna M. Stone, Kalpana M. Merchant, Glen R. Hanson et al.

In the rat, administration of the psychoactive analog of amphetamine 3,4-methylenedioxymethamphetamine (MDMA), causes selective, pronounced decreases in markers of central serotonergic function. The time course of these neurochemical changes was examined in several serotonergic nerve terminal regions of the brain. Fifteen min after subcutaneous injection of MDMA (10 mg/kg), the enzymatic...

Electrophysiological effects of phencyclidine in the medial prefrontal cortex of the rat.

Neuropharmacology September 1987 A Gratton, B J Hoffer, R Freedman

The effects of local applications of phencyclidine (PCP) and dopamine (DA) on neurons of the medial prefrontal cortex were investigated using single unit recording techniques. The activity of the majority of cells in the deeper layers of the medial prefrontal cortex was depressed by both phencyclidine and DA, whereas increases, as well as decreases, in the firing rates were observed in cells...

Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat.

Fundamental and applied toxicology : official journal of the Society of Toxicology July 1, 1987 C H Frith, L W Chang, D L Lattin et al.

Methylenedioxymethamphetamine (MDMA) was administered to dogs and rats orally once a day for a 28-day period to evaluate the morphological and neuropathological effects. Major clinical signs associated with the administration of MDMA in the dog included circling, depression, dilated pupils, hyperactivity, rapid breathing, and salivation. Major clinical signs in the rat included hyperactivity,...

Dose-dependent effects of phencyclidine on hippocampal CA1 neurons.

Canadian journal of physiology and pharmacology May 1987 P W Kujtan, P L Carlen

The dose-dependent effects of phencyclidine were examined in guinea pig hippocampal slices using intracellular and extracellular recordings. Orthodromically evoked population potentials from the CA1 cell body layer were enhanced by low doses (0.2-0.4 microM) and depressed by high doses (0.01-10 mM). Medium doses of the drug (2.0-10.0 microM) showed little effect. Intracellular recordings from...

Neonatal manifestations of maternal phencyclidine exposure.

Journal of perinatal medicine 1987 N L Golden, B R Kuhnert, R J Sokol et al.

The purpose of this study was to determine the effects of maternal phencyclidine use on the fetus. Ninety-four neonates with maternal phencyclidine exposure were compared with 94 controls. Maternal phencyclidine use was assessed by questionnaire and repeated urine testing. Mothers of study and control patients were matched for demographic characteristics. Infants were assessed between 24-72...

Mescaline-induced motor impairment in rats, assessed by two different methods

Life Sciences September 1, 1986 Elizabeth A. Sykes 10 citations

Motor impairment, especially ataxia, is often mentioned as a 'side effect' of doses of psychoactive drugs which depress animal behaviour; it is difficult to determine it accurately from visual observation, but relatively few attempts have been made to measure it objectively and quantitatively. Mescaline, in moderate to large doses, can induce biphasic--depressant followed by stimulant--effects...

DOI: 10.1016/0024-3205(86)90196-7 (opens in new tab) Mescaline Ataxia Motor activity Pharmacology +4

Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects.

Pharmacology, Biochemistry, and Behavior June 1986 E J Cone, R E Johnson, J D Moore et al.

Four healthy male subjects smoked two marijuana cigarettes or one marijuana cigarette and one placebo cigarette, or two placebo cigarettes on separate days in a random order crossover design. Each marijuana cigarette contained 2.8% delta-9-tetrahydrocannabinol (THC). Plasma hormones and THC were measured before and after each smoking session. Plasma LH was significantly depressed and cortisol...

Cellular effects of cannabinoids.

Pharmacological Reviews March 1, 1986 B. Martin

The many studies that have been included in this review suggest that cannabinoids have ubiquitous effects on biological systems. These results also underscore the intensity to which cannabinoids have been studied. While there are numerous reasons for the prodigious amount of cannabinoid research, a major stimulus has been the desire to identify a specific biochemical event or pathway that is...